These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 26437625)

  • 81. Contrast-enhanced MR cholangiography (MRCP) with GD-EOB-DTPA in evaluating biliary complications after surgery.
    Salvolini L; Urbinati C; Valeri G; Ferrara C; Giovagnoni A
    Radiol Med; 2012 Apr; 117(3):354-68. PubMed ID: 22020424
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Differentiation of small (≤2 cm) hepatocellular carcinomas from small benign nodules in cirrhotic liver on gadoxetic acid-enhanced and diffusion-weighted magnetic resonance images.
    Kwon HJ; Byun JH; Kim JY; Hong GS; Won HJ; Shin YM; Kim PN
    Abdom Imaging; 2015 Jan; 40(1):64-75. PubMed ID: 24997560
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver.
    Xu PJ; Yan FH; Wang JH; Shan Y; Ji Y; Chen CZ
    J Comput Assist Tomogr; 2010 Jul; 34(4):506-12. PubMed ID: 20657216
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Gadoxetic acid-enhanced MRI of transient hepatic enhancement differences: Another cause of hypointense observation on hepatobiliary phase.
    Torrisi C; Picone D; Cabibbo G; Matranga D; Midiri M; Brancatelli G
    Eur J Radiol; 2018 Oct; 107():39-45. PubMed ID: 30292271
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Value of contrast-enhanced magnetic resonance cholangiography in patients undergoing laparoscopic cholecystectomy.
    Mutlu H; Basekim CC; Silit E; Pekkafali Z; Erenoglu C; Kantarci M; Karsli AF; Kizilkaya E
    Surg Laparosc Endosc Percutan Tech; 2005 Aug; 15(4):195-8; discussion 198-201. PubMed ID: 16082305
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Enhancement of the liver and pancreas in the hepatic arterial dominant phase: comparison of hepatocyte-specific MRI contrast agents, gadoxetic acid and gadobenate dimeglumine, on 3 and 1.5 Tesla MRI in the same patient.
    Kim HJ; Kim BS; Kim MJ; Kim SH; de Campos RO; Hernandes M; Semelka RC
    J Magn Reson Imaging; 2013 Apr; 37(4):903-8. PubMed ID: 23065959
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Value of MR cholangiography in the diagnosis of obstructive diseases of the biliary tree: a study of 58 cases.
    Mendler MH; Bouillet P; Sautereau D; Chaumerliac P; Cessot F; Le Sidaner A; Pillegand B
    Am J Gastroenterol; 1998 Dec; 93(12):2482-90. PubMed ID: 9860413
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Gadoxetic acid-enhanced magnetic resonance imaging for differentiating small hepatocellular carcinomas (< or =2 cm in diameter) from arterial enhancing pseudolesions: special emphasis on hepatobiliary phase imaging.
    Sun HY; Lee JM; Shin CI; Lee DH; Moon SK; Kim KW; Han JK; Choi BI
    Invest Radiol; 2010 Feb; 45(2):96-103. PubMed ID: 20057319
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Flip angle modulations in late phase Gd-EOB-DTPA MRI improve the identification of the biliary system.
    Stelter L; Grieser C; Fernándes CM; Rothe JH; Streitparth F; Seehofer D; Hamm B; Denecke T
    Eur J Radiol; 2012 Nov; 81(11):e991-5. PubMed ID: 22884706
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Breathhold unenhanced and gadolinium-enhanced magnetic resonance tomography and magnetic resonance cholangiography in hilar cholangiocarcinoma.
    Altehoefer C; Ghanem N; Furtwängler A; Schneider B; Langer M
    Int J Colorectal Dis; 2001 Jun; 16(3):188-92. PubMed ID: 11459293
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease.
    Ichikawa T; Saito K; Yoshioka N; Tanimoto A; Gokan T; Takehara Y; Kamura T; Gabata T; Murakami T; Ito K; Hirohashi S; Nishie A; Saito Y; Onaya H; Kuwatsuru R; Morimoto A; Ueda K; Kurauchi M; Breuer J
    Invest Radiol; 2010 Mar; 45(3):133-41. PubMed ID: 20098330
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Differentiation of hepatic hyperintense lesions seen on gadoxetic acid-enhanced hepatobiliary phase MRI.
    Suh YJ; Kim MJ; Choi JY; Park YN; Park MS; Kim KW
    AJR Am J Roentgenol; 2011 Jul; 197(1):W44-52. PubMed ID: 21700994
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Detection and characterization of traumatic bile leaks using Gd-EOB-DTPA enhanced magnetic resonance cholangiography.
    Wong YC; Wang LJ; Wu CH; Chen HW; Fu CJ; Yuan KC; Lin BC; Hsu YP; Kang SC
    Sci Rep; 2018 Oct; 8(1):14612. PubMed ID: 30279434
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Gd-EOB-DTPA-enhanced MR imaging: evaluation of hepatic enhancement effects in normal and cirrhotic livers.
    Tamada T; Ito K; Higaki A; Yoshida K; Kanki A; Sato T; Higashi H; Sone T
    Eur J Radiol; 2011 Dec; 80(3):e311-6. PubMed ID: 21315529
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Small hepatocellular carcinomas: improved sensitivity by combining gadoxetic acid-enhanced and diffusion-weighted MR imaging patterns.
    Park MJ; Kim YK; Lee MW; Lee WJ; Kim YS; Kim SH; Choi D; Rhim H
    Radiology; 2012 Sep; 264(3):761-70. PubMed ID: 22843769
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Which is the best MRI marker of malignancy for atypical cirrhotic nodules: hypointensity in hepatobiliary phase alone or combined with other features? Classification after Gd-EOB-DTPA administration.
    Golfieri R; Grazioli L; Orlando E; Dormi A; Lucidi V; Corcioni B; Dettori E; Romanini L; Renzulli M
    J Magn Reson Imaging; 2012 Sep; 36(3):648-57. PubMed ID: 22592930
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Biliary ductal involvement of hilar cholangiocarcinoma: multidetector computed tomography versus magnetic resonance cholangiography.
    Cho ES; Park MS; Yu JS; Kim MJ; Kim KW
    J Comput Assist Tomogr; 2007; 31(1):72-8. PubMed ID: 17259836
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Improved management of grade B biliary leaks after complex liver resections using gadoxetic acid disodium-enhanced magnetic resonance cholangiography.
    Citterio D; Vaiani M; Sposito C; Rossi RE; Flores M; Battiston C; Mazzaferro V
    Surgery; 2021 Aug; 170(2):499-506. PubMed ID: 33745732
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Optimal T2-weighted MR cholangiopancreatographic images can be obtained after administration of gadoxetic acid.
    Kim KA; Kim MJ; Park MS; Lim JS; Choi JY; Hong HS; Kim KW
    Radiology; 2010 Aug; 256(2):475-84. PubMed ID: 20656837
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Magnetic resonance cholangiography: Current and future perspectives.
    Arrivé L; Hodoul M; Arbache A; Slavikova-Boucher L; Menu Y; El Mouhadi S
    Clin Res Hepatol Gastroenterol; 2015 Dec; 39(6):659-64. PubMed ID: 26275724
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.